Placebo NaCl 0.9% solution i.v. on day 1 of every 21 days cycle for 2 cycles.
Phase 2
Placebo NaCl 0.9% solution i.v. on day 1 of every 21 days cycle for 2 cycles. is one of 2 therapeutic programs targeting Merkel Cell Carcinoma, Stage I. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
1 competitor in Merkel Cell Carcinoma, Stage I
#DrugCompanyPhaseTrials
1Libtayo
RegeneronPhase 2
Placebo NaCl 0.9% solution i.v. on day 1 of every 21 days cycle for 2 cycles.
IInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]